RESEARCH TRIANGLE PARK, N.C. April 23, 2012 Windows Azure
TeraDiscoveries will use its Inverse Design software that runs computational models to quickly scan virtual chemical libraries to find the strongest inhibitors of a specific biological target. The process identifies novel drug candidates that feature good clinical trial properties and demonstrate low probability of toxic side effects.
Companies can license Inverse Design and run it on Windows Azure to design, discover, or optimize new small molecule or peptide drugs for their targets. TeraDiscoveries also provides drug discovery services for companies seeking outside assistance.
Bio-IT World Conference & Expo April 24 to 26, 2012 Boston
About TeraDiscoveries, Inc.
All product and company names herein may be trademarks of their respective owners.
SOURCE TeraDiscoveries, Inc.